Baseline and on-treatment predictors of chronic hepatitis B patients receiving pegylated interferon therapy in Asia
Of currently available drugs for the treatment of chronic hepatitis B, pegylated interferon (peg-IFN) offers the highest rate of off-treatment sustained response with the finite course of treatment in the absence of viral resistance. However, its clinical use is compromised by the frequent occurrenc...
Saved in:
Main Authors: | Phunchai Charatcharoenwitthaya, Teerha Piratvisuth |
---|---|
Other Authors: | Mahidol University |
Format: | Review |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/31878 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Next generation sequencing identifies baseline viral mutants associated with treatment response to pegylated interferon in HBeAg-positive chronic hepatitis B
by: Natthaya Chuaypen, et al.
Published: (2020) -
Baseline and kinetics of serum hepatitis B virus RNA predict response to pegylated interferon-based therapy in patients with hepatitis B e antigen-negative chronic hepatitis B
by: Umaporn Limothai, et al.
Published: (2020) -
Association of the S267F variant on NTCP gene and treatment response to pegylated interferon in patients with chronic hepatitis B: A multicentre study
by: Kessarin Thanapirom, et al.
Published: (2018) -
Controversies in Treating Chronic HBV: The Role of PEG-interferon-alfa
by: Phunchai Charatcharoenwitthaya, et al.
Published: (2022) -
Genetic variation in STAT4 is associated with treatment response to pegylated interferon in patients with chronic hepatitis B
by: Umaporn Limothai, et al.
Published: (2022)